Qiagen NV at UBS Global Healthcare Conference Transcript
Hi, I'm John Sourbeer. I cover Life Science Tools and Pharma Services at UBS. For our next fireside chat, we have QIAGEN. And with us today is CEO, Thierry Bernard. Hi, Thierry.
Thank you.
Questions & Answers
And a reminder: if you like, we have iPads up here. And through the UBS app, you can ask a question if you have any questions in the audience. So Thierry, I figured just to start things off, COVID testing continues to be a topic of interest.
Can you just talk a little bit about the cadence of the COVID testing guidance for the year? I think it's $14 million. And then -- how do you see this normalizing as we see cases drop throughout the year?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
